DALLAS, July 28, 2015 /PRNewswire/ --
RnRMarketResearch.com adds 2015 edition octreotide market research reports providing forecasts to 2021, China octreotide industry investigation analysis to 2019, comprehensive patent search and more to the pharmaceuticals collection of its library.
The complete Global Octreotide Market Report 2015 spread across 124 pages, profiling 7 companies and supported with 169 tables and figures is now available at http://www.rnrmarketresearch.com/global-octreotide-industry-report-2015-market-report.html .
This is a professional and in-depth study on the current state of the octreotide market that provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The octreotide market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Octreotide industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.
This 2015 octreotide market research focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The octreotide market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 169 tables and figure to support the octreotide market analysis, this report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Companies profiled in this research include Novartis, Sun Pharmaceutical, Chengdu Tiantaishan Pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals and Yibin Pharmaceutical. Order a copy of Global Octreotide Industry Report 2015 at http://www.rnrmarketresearch.com/contacts/purchase?rname=395975 .
The second research titled Investigation Report on China Octreotide Market, 2010-2019 says market size of Octreotide in China is expected to keep growing in the next few years. Due to its sure efficacy and various indications, Octreotide has become one of the most highly stressed biosimilar compounds. Octreotide has remained a steady growth ever since its listing and its sales value surpassed USD 1000 million in 2007. Sandostatin's US patent expired in Jun. 2014. Although the generic drug of Octreotide made by Sun Pharmaceutical Industries Ltd got FDA's approval in 2008, Novartis's Octreotide still brought in sales revenue of USD 1589 million in 2013.
After Octreotide made by Novartis entered China in 2004, many local generic drugs came into the market successively. Octreotide has undergone a fast development in China with annual sales value rising from CNY 100 million in 2005 to CNY 466 million in 2014 and CAGR reaching up to 15.8% during the period of 2005-2014. Octreotide enjoys a vast demand in China. Novartis AG (Sweden), Chengdu Tiantaishan Pharmaceutical Co., Ltd, Sinopharm A-THINK Pharmaceutical Co., Ltd, Peking Sunho Pharmaceutical Co., Ltd and Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd all take up certain shares in the Chinese market, among which Novartis AG (Sweden) has the largest market share of over 70%, sales value in 2014 reaching up to CNY 334 million in 2014.
One of the chapters in this report provide information on reference price of octreotide in Chinese hospitals in 2014 covering Sandoz GmbH (AT) (Trade Name: Sandostatin LAR), Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd, Wellso Pharmaceutical Co., Ltd, Peking Sunho Pharmaceutical Co., Ltd, Sinopharm A-THINK Pharmaceutical CoE., Ltd, GeneScience Pharmaceuticals Co., Ltd, Chengdu Tiantaishan Pharmaceutical Co., Ltd and Novartis AG (Sweden) (Trade Name: Sandostatin LAR). Major manufacturers of octreotide in Chinese market for 2010-2014 discussed in this research include Novartis AG (Switzerland), Chengdu Tiantaishan Pharmaceutical Co., Ltd, Sinopharm A-THINK Pharmaceutical Co., Ltd, Peking Sunho Pharmaceutical Co., Ltd and Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd. Comprehensive table of contents and more on Investigation Report on China Octreotide Market, 2010-2019 is available at http://www.rnrmarketresearch.com/investigation-report-on-china-octreotide-market-2010-2019-market-report.html .
The third research titled Octreotide - Comprehensive patent search contains patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. This report covers information on International Nonproprietary Name: Octreotide, Indications: Acromegaly; Gastroentero-pancreatic endocrine tumours and Innovator:Novartis (Sandostatin, Sandostatin LAR). The in-depth search features of this report include comprehensive patent searching, covering the world's key territories, identifies patents covering molecule, formulation, process, use, combinations and more (see 'Patent Categories Identified below), patent identification, categorisation and interpretation, grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims, comprehensive litigation alerts linked to patent numbers, monthly updates to patent families, statuses, and litigation clearly identified, enables fast analysis and verification by hyper-linking to crucial patent documents and national registers and add your own notes, save searches and results. Read more at http://www.rnrmarketresearch.com/octreotide-comprehensive-patent-search-market-report.html .
Explore more reports on the pharmaceuticals market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
Twitter: https://twitter.com/RnRMR
Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345
RSS / Feeds: http://www.rnrmarketresearch.com/feed
Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales@rnrmarketresearch.com
SOURCE RnR Market Research
Share this article